3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Leukemia, Myeloid, Acute
104
Multiple Myeloma
66
Lymphoma
60
Precursor Cell Lymphoblastic Leukemia-Lymphoma
57
Myelodysplastic Syndromes
51
Lymphoma, Non-Hodgkin
51
Leukemia
50
Hodgkin Disease
42
Lymphoma, Mantle-Cell
29
Lymphoma, Large B-Cell, Diffuse
29
Leukemia, Lymphocytic, Chronic, B-Cell
26
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
23
Lymphoma, Follicular
22
Burkitt Lymphoma
22
Breast Neoplasms
22
Recurrence
20
Neoplasms, Plasma Cell
18
Neuroblastoma
17
Hematologic Neoplasms
17
Lymphoma, B-Cell, Marginal Zone
15
Myeloproliferative Disorders
14
Lymphoma, Large-Cell, Immunoblastic
14
Leukemia, Myelomonocytic, Chronic
12
Leukemia, Biphenotypic, Acute
12
Congenital Abnormalities
12
Blast Crisis
10
Anemia, Refractory, with Excess of Blasts
10
Retinoblastoma
9
Central Nervous System Neoplasms
9
Sarcoma
8
Interventions
Ifosfamide
2
Doxorubicin
2
Cyclophosphamide
2
tebentafusp
1
selinexor
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
pazopanib
1
fludarabine phosphate
1
fludarabine
1
cobimetinib
1
Zoledronic Acid
1
Vemurafenib
1
Topotecan
1
Sunitinib
1
Sirolimus
1
Simvastatin
1
Radiotherapy, Image-Guided
1
Radiation Dose Hypofractionation
1
Proton Therapy
1
Nivolumab
1
Methotrexate
1
Mesna
1
Granulocyte Colony-Stimulating Factor
1
Epirubicin
1
Diathermy
1
Dacarbazine
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Sarcoma, Clear Cell
×
Granulocyte Colony-Stimulating Factor
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled